Serine/threonine kinase 32 family proteins: The potential multifaceted regulators in cancer

As a subgroup of AGC kinases, serine/threonine kinase 32 family (STK32, also known as Yet Another Novel Kinases family) consists of three members: STK32A, STK32B and STK32C. Recently, emerging evidences have implicated the aberrant expression and dysregulated functions of STK32 kinases in human malignancies. However, there is a lack of systematic review on this topic. Here, we aim to detailly examine the expression and functional features of STK32 family kinases within the context of present reports and public datasets related, and outline current understanding on the multifunctional roles and up-stream regulatory mechanisms and down-stream effectors of STK32 kinases to highlight key research focus for future exploration and provide rationale for developing STK32-targeted therapeutics in cancer.

Authors

Institutions

Publication Details

Journal
Translational Oncology
Published
2025-11-22
DOI
https://doi.org/10.1016/j.tranon.2025.102608
Primary Topic
Melanoma and MAPK Pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serine/threonine kinase 32 family proteins: The potential multifaceted regulators in cancer

Cheng Peng, Longqiao Liu, Lin Li Cheng, Yang Liu et al.
Translational Oncology
Melanoma and MAPK Pathways
article

Serine/threonine kinase 32 family proteins: The potential multifaceted regulators in cancer

Cheng Peng, Longqiao Liu, Lin Li Cheng, Yang Liu, Yuan Feng
article en

Abstract

As a subgroup of AGC kinases, serine/threonine kinase 32 family (STK32, also known as Yet Another Novel Kinases family) consists of three members: STK32A, STK32B and STK32C. Recently, emerging evidences have implicated the aberrant expression and dysregulated functions of STK32 kinases in human malignancies. However, there is a lack of systematic review on this topic. Here, we aim to detailly examine the expression and functional features of STK32 family kinases within the context of present reports and public datasets related, and outline current understanding on the multifunctional roles and up-stream regulatory mechanisms and down-stream effectors of STK32 kinases to highlight key research focus for future exploration and provide rationale for developing STK32-targeted therapeutics in cancer.

Translational OncologyVol. 63
First Hospital of China Medical University (CN), China Medical University (CN)
Openalex Percentile: Top 68%
Melanoma and MAPK Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Serine/threonine kinase 32 family proteins: The potential multifaceted regulators in cancer — Cheng Peng, Longqiao Liu, et al. · Translational Oncology (2025) | TGRS Research Map | TGRS